Yanmin Zhao[Author] - Search Results

Year	Number of Results
2005	1
2007	1
2008	3
2009	4
2010	1
2011	4
2012	2
2013	6
2014	8
2015	2
2016	6
2017	6
2018	4
2019	9
2020	23
2021	20
2022	18
2023	17
2024	18

1

Interplay between metabolic reprogramming and post-translational modifications: from glycolysis to lactylation.

Wu H, Huang H, Zhao Y. Wu H, et al. Among authors: zhao y. Front Immunol. 2023 Jun 29;14:1211221. doi: 10.3389/fimmu.2023.1211221. eCollection 2023. Front Immunol. 2023. PMID: 37457701 Free PMC article. Review.

2

Altered intestinal microbiome and epithelial damage aggravate intestinal graft-versus-host disease.

Gao F, Wu H, Wang L, Zhao Y, Huang H. Gao F, et al. Among authors: zhao y. Gut Microbes. 2023 Jan-Dec;15(1):2221821. doi: 10.1080/19490976.2023.2221821. Gut Microbes. 2023. PMID: 37305973 Free PMC article. Review.

3

TP53 in MDS and AML: Biological and clinical advances.

Zhao Y, Chen W, Yu J, Pei S, Zhang Q, Shi J, Huang H, Zhao Y. Zhao Y, et al. Cancer Lett. 2024 Apr 28;588:216767. doi: 10.1016/j.canlet.2024.216767. Epub 2024 Feb 27. Cancer Lett. 2024. PMID: 38417666 Review.

4

Novel immunotherapies for adult patients with B-lineage acute lymphoblastic leukemia.

Wei G, Wang J, Huang H, Zhao Y. Wei G, et al. Among authors: zhao y. J Hematol Oncol. 2017 Aug 18;10(1):150. doi: 10.1186/s13045-017-0516-x. J Hematol Oncol. 2017. PMID: 28821272 Free PMC article. Review.

5

Mechanisms and rejuvenation strategies for aged hematopoietic stem cells.

Li X, Zeng X, Xu Y, Wang B, Zhao Y, Lai X, Qian P, Huang H. Li X, et al. Among authors: zhao y. J Hematol Oncol. 2020 Apr 6;13(1):31. doi: 10.1186/s13045-020-00864-8. J Hematol Oncol. 2020. PMID: 32252797 Free PMC article. Review.

6

Chemical constituents and pharmacological activities of medicinal plants from Rosa genus.

Wang Y, Zhao Y, Liu X, Li J, Zhang J, Liu D. Wang Y, et al. Among authors: zhao y. Chin Herb Med. 2022 Mar 31;14(2):187-209. doi: 10.1016/j.chmed.2022.01.005. eCollection 2022 Apr. Chin Herb Med. 2022. PMID: 36117670 Free PMC article. Review.

7

Outcome after allogeneic hematopoietic stem cell transplantation following Venetoclax-based therapy among AML and MDS patients.

Yang TT, Song XL, Zhao YM, Ye BD, Luo Y, Xiao HW, Chen Y, Fu HR, Yu J, Liu LZ, Lai XY, Ye YS, Lan JP, Huang H, Shi JM. Yang TT, et al. Ann Hematol. 2022 Dec;101(12):2731-2741. doi: 10.1007/s00277-022-04983-9. Epub 2022 Nov 1. Ann Hematol. 2022. PMID: 36318288

8

Insights from TARGET-seq: Inflammation drives TP53-mediated clonal evolution.

Zhao Y, Huo W, Liang Y, Mo X, Pei S, Zhao Y. Zhao Y, et al. Innovation (Camb). 2024 Jan 5;5(2):100572. doi: 10.1016/j.xinn.2024.100572. eCollection 2024 Mar 4. Innovation (Camb). 2024. PMID: 38344324 Free PMC article. Review. No abstract available.

9

Double filtration plasmapheresis combined with rituximab for donor-specific antibody desensitization in haploidentical haematopoietic stem cell transplantation.

Liu L, Ji X, Zhu P, Yang L, Shi J, Zhao Y, Lai X, Yu J, Fu H, Ye Y, Wu Y, Ying J, Huang H, Luo Y. Liu L, et al. Among authors: zhao y. Br J Haematol. 2023 Dec;203(5):829-839. doi: 10.1111/bjh.19046. Epub 2023 Aug 24. Br J Haematol. 2023. PMID: 37621146

10

Immunomodulatory Effects of Histone Deacetylation Inhibitors in Graft-vs.-Host Disease After Allogeneic Stem Cell Transplantation.

Xu X, Li X, Zhao Y, Huang H. Xu X, et al. Among authors: zhao y. Front Immunol. 2021 Feb 24;12:641910. doi: 10.3389/fimmu.2021.641910. eCollection 2021. Front Immunol. 2021. PMID: 33732262 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

135 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

135 results

Results by year